Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000510
Filing Date
2025-03-27
Accepted
2025-03-27 16:03:22
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20241231x10k.htm   iXBRL 10-K 1956561
2 EX-31.1 tmb-20241231xex31d1.htm EX-31.1 13709
3 EX-32.1 tmb-20241231xex32d1.htm EX-32.1 8482
4 GRAPHIC tmb-20241231x10k001.jpg GRAPHIC 5726
5 GRAPHIC tmb-20241231x10k002.jpg GRAPHIC 3395
  Complete submission text file 0001410578-25-000510.txt   8902295

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20241231.xsd EX-101.SCH 76340
7 EX-101.CAL tmb-20241231_cal.xml EX-101.CAL 59257
8 EX-101.DEF tmb-20241231_def.xml EX-101.DEF 226869
9 EX-101.LAB tmb-20241231_lab.xml EX-101.LAB 497526
10 EX-101.PRE tmb-20241231_pre.xml EX-101.PRE 437534
99 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241231x10k_htm.xml XML 1474417
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

EIN.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55066 | Film No.: 25779222
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)